Protagonist Therapeutics (PTGX) AI Analysis
PTGX$130.95-3.43 -2.55%
Market cap$8.55BEnterprise value$8.28BRevenue (TTM)$551.69MMarket position—
Score
68
Bullish
Value
34
Quality
77
Growth
93
AI Score 65. Protagonist Therapeutics, Inc. has a market cap of $9.28 billion and is engaged in promising Phase II clinical trials for its therapies, indicating potential growth